Immunoblot Analysis of Plasma GDF11

RT Rie Tanaka
AK Akira Koarai
MY Mitsuhiro Yamada
NF Naoya Fujino
TI Tomohiro Ichikawa
TN Tadahisa Numakura
KO Katsuhiro Onodera
YK Yorihiko Kyogoku
TT Tsutomu Tamada
MM Motohiko Miura
YM Yoshiaki Minakata
MI Masakazu Ichinose
HS Hisatoshi Sugiura
ask Ask a question
Favorite

Immunoblot analysis of the plasma GDF11 levels was performed as described previously.18,19 The plasma samples were diluted with saline and the diluted samples were mixed with sample buffer (Bio-Rad Laboratories, Hercules, CA). The samples containing 50 µg of protein were loaded and separated by electrophoresis on 10% SDS polyacrylamide gels. In addition to the samples, in order to compare samples from separate gels, 50 µg of a particular sample was loaded. After electrophoresis, the separated proteins were transferred to a PVDF membrane (Merck Millipore Ltd., Darmstadt, Germany). We used an antibody raised against GDF11 specifically (1:1000 dilution, R&D Systems Inc., Minneapolis, MN).18 Bound antibodies were visualized using a peroxidase-conjugated anti-mouse goat antibody (1:2000 dilution, Santa Cruz Biotechnology Inc., Dallas, TX) and enhanced chemiluminescence (GE Healthcare Ltd., Buckinghamshire, UK) with a chemiluminescence imaging system (LAS-4000 mini; Fujifilm CO., Tokyo, Japan). Ponceau S staining was used to evaluate the amounts of protein. The GDF11 levels were calculated by measuring the intensity of the bands. Band intensity was quantified using ImageJ 1.52v software (National Institutes of Health, Bethesda, MD). In order to compare across blots, the protein levels were normalized against a particular sample.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A